| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1105560469 |
| P356 | DOI | 10.1186/S12935-018-0597-9 |
| P932 | PMC publication ID | 6044050 |
| P698 | PubMed publication ID | 30008617 |
| P50 | author | Ling Wang | Q90219105 |
| P2093 | author name string | Li Wang | |
| Chao Yang | |||
| Fu-Biao Kang | |||
| Xin-Bo Liu | |||
| P2860 | cites work | Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner | Q24337323 |
| B7x: a widely expressed B7 family member that inhibits T cell activation | Q24683252 | ||
| Immunobiology and immunotherapy in genitourinary malignancies | Q26738668 | ||
| B7-H4 as a potential target for immunotherapy for gynecologic cancers: a closer look | Q26824446 | ||
| Current advances in biomarkers for targeted therapy in triple-negative breast cancer | Q28074202 | ||
| The Impact of Chemotherapy, Radiation and Epigenetic Modifiers in Cancer Cell Expression of Immune Inhibitory and Stimulatory Molecules and Anti-Tumor Efficacy | Q28076473 | ||
| Triple-negative breast cancer: is there a treatment on the horizon? | Q28077243 | ||
| Concepts and targets in triple-negative breast cancer: recent results and clinical implications | Q28078992 | ||
| The B7 family revisited | Q28240070 | ||
| Pten loss promotes MAPK pathway dependency in HER2/neu breast carcinomas | Q28602310 | ||
| Cancer Immunology and Immunotherapy | Q30275573 | ||
| Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease | Q33769821 | ||
| B7-H4 expression indicates poor prognosis of oral squamous cell carcinoma | Q39627356 | ||
| Cell cycle arrest induced by engagement of B7-H4 on Epstein-Barr virus-positive B-cell lymphoma cell lines | Q39753163 | ||
| MDA-MB-435 and M14 cell lines: identical but not M14 melanoma? | Q39834203 | ||
| FAK goes nuclear to control antitumor immunity-a new target in cancer immuno-therapy | Q40437517 | ||
| B7-H4 expression in ovarian serous carcinoma: a study of 306 cases | Q40523803 | ||
| Lineage infidelity of MDA-MB-435 cells: expression of melanocyte proteins in a breast cancer cell line | Q40554428 | ||
| T-cell infiltration and expressions of T lymphocyte co-inhibitory B7-H1 and B7-H4 molecules among colorectal cancer patients in northeast China's Heilongjiang province | Q42254317 | ||
| B7-H4 expression by nonhematopoietic cells in the tumor microenvironment promotes antitumor immunity. | Q47571058 | ||
| Antitumor immunity and advances in cancer immunotherapy. | Q51306282 | ||
| Prognostic values of B7-H4 in non-small cell lung cancer. | Q51504733 | ||
| Impact of neoadjuvant chemotherapy on lymphocytes and co-inhibitory B7-H4 molecule in gastric cancer: low B7-H4 expression associates with favorable prognosis | Q85642862 | ||
| B7-H1 and B7-H4 expression in colorectal carcinoma: correlation with tumor FOXP3(+) regulatory T-cell infiltration | Q87428646 | ||
| B7-H4, a molecule of the B7 family, negatively regulates T cell immunity | Q34207473 | ||
| B7S1, a novel B7 family member that negatively regulates T cell activation | Q34207477 | ||
| Genomic Organization and Expression Analysis of B7-H4, an Immune Inhibitory Molecule of the B7 Family | Q34271293 | ||
| The new B7s: playing a pivotal role in tumor immunity | Q34616690 | ||
| B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration | Q34629311 | ||
| B7-H4 is a positive regulator of antitumor immunity | Q36597328 | ||
| Host b7x promotes pulmonary metastasis of breast cancer | Q36718223 | ||
| B7-H4(B7x)-Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL6/JAK/STAT3 Pathway Lead to Poor Prognosis in Glioma Patients | Q36963632 | ||
| Prostate derived Ets transcription factor and Carcinoembryonic antigen related cell adhesion molecule 6 constitute a highly active oncogenic axis in breast cancer | Q37038409 | ||
| Higher preoperative serum levels of PD-L1 and B7-H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF-targeted therapy and unfavorable prognosis of renal cell carcinoma | Q37148917 | ||
| Predicting disease progression after nephrectomy for localized renal cell carcinoma: the utility of prognostic models and molecular biomarkers | Q37181866 | ||
| The Effect of Molecular Subtype and Residual Disease on Locoregional Recurrence in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Postmastectomy Radiation | Q37217746 | ||
| Fine tuning the immune response through B7-H3 and B7-H4 | Q37227080 | ||
| Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance | Q37330473 | ||
| WWP2 is an E3 ubiquitin ligase for PTEN. | Q37588182 | ||
| Geridonin and paclitaxel act synergistically to inhibit the proliferation of gastric cancer cells through ROS-mediated regulation of the PTEN/PI3K/Akt pathway | Q37687329 | ||
| Paradoxical induction of growth arrest and apoptosis by EGF via the up-regulation of PTEN by activating Redox factor-1/Egr-1 in human lung cancer cells | Q37706156 | ||
| Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer | Q37708804 | ||
| B7-H4 promotes tumor growth and metastatic progression in lung cancer by impacting cell proliferation and survival | Q37745860 | ||
| A review of B7-H3 and B7-H4 immune molecules and their role in ovarian cancer. | Q38036543 | ||
| Myoepithelial and epithelial-myoepithelial, mesenchymal and fibroepithelial breast lesions: updates from the WHO Classification of Tumours of the Breast 2012. | Q38093560 | ||
| B7-H3-mediated tumor immunology: Friend or foe? | Q38135281 | ||
| Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer: Evidence From a Phase 1 Trial of mTOR Inhibition in Combination With Liposomal Doxorubicin and Bevacizumab | Q38377100 | ||
| Long noncoding RNA GAS5 inhibits malignant proliferation and chemotherapy resistance to doxorubicin in bladder transitional cell carcinoma | Q38729421 | ||
| Systematic Drug Screening Identifies Tractable Targeted Combination Therapies in Triple-Negative Breast Cancer | Q38729732 | ||
| Roles of coinhibitory molecules B7-H3 and B7-H4 in esophageal squamous cell carcinoma | Q38832039 | ||
| A second chance for telomerase reverse transcriptase in anticancer immunotherapy | Q38849194 | ||
| An anti-B7-H4 antibody-drug conjugate for the treatment of breast cancer | Q38889780 | ||
| Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade | Q38895750 | ||
| Targeted therapy for breast cancer and molecular mechanisms of resistance to treatment | Q39018818 | ||
| Effective down-regulation of signal transducer and activator of transcription 3 (STAT3) by polyplexes of siRNA and lipid-substituted polyethyleneimine for sensitization of breast tumor cells to conventional chemotherapy. | Q39069248 | ||
| PTEN/PI3K/AKT protein expression is related to clinicopathological features and prognosis in breast cancer with axillary lymph node metastases | Q39173376 | ||
| B7-h4 expression in human melanoma: its association with patients' survival and antitumor immune response | Q39580692 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cancer research | Q3421914 |
| drug resistance | Q12147416 | ||
| overexpression | Q61643320 | ||
| P304 | page(s) | 100 | |
| P577 | publication date | 2018-07-13 | |
| P1433 | published in | Cancer Cell International | Q1829859 |
| P1476 | title | B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer | |
| P478 | volume | 18 |
| Q98159046 | Overexpression of B7-H4 promotes renal cell carcinoma progression by recruiting tumor-associated neutrophils via upregulation of CXCL8 |
| Q59813353 | Rapid Synthesis of -Tosylhydrazones under Solvent-Free Conditions and Their Potential Application Against Human Triple-Negative Breast Cancer |
Search more.